{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:38:07Z","timestamp":1787503087926,"version":"build-2736575974"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,18]]},"DOI":"10.7759\/cureus.99539","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T13:42:01Z","timestamp":1766065321000},"source":"Crossref","is-referenced-by-count":1,"title":["Learning From the Uncommon in Common Practice: A Case Report on Metamizole-Induced Agranulocytosis"],"prefix":"10.7759","author":[{"given":"Marisa","family":"Cunha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa","family":"Fonseca-Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Marinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An\u00edbal","family":"Marinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s40348-023-00160-8","article-title":"Metamizole-induced agranulocytosis (MIA): a mini review","volume":"10","author":"Tomidis Chatzimanouil MK","year":"2023","unstructured":"Tomidis Chatzimanouil MK, Goppelt I, Zeissig Y, Sachs UJ, Laass MW. Metamizole-induced agranulocytosis (MIA): a mini review. Mol Cell Pediatr. 2023, 10:6. 10.1186\/s40348-023-00160-8","journal-title":"Mol Cell Pediatr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1777-8","article-title":"Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study","volume":"71","author":"Huber M","year":"2015","unstructured":"Huber M, Andersohn F, Sarganas G, et al.. Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study. Eur J Clin Pharmacol. 2015, 71:219-27. 10.1007\/s00228-014-1777-8","journal-title":"Eur J Clin Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20489","article-title":"Relative incidence of agranulocytosis and aplastic anemia","volume":"81","author":"Kaufman DW","year":"2006","unstructured":"Kaufman DW, Kelly JP, Issaragrisil S, et al.. Relative incidence of agranulocytosis and aplastic anemia. Am J Hematol. 2006, 81:65-7. 10.1002\/ajh.20489","journal-title":"Am J Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1781-z","article-title":"Hematological safety of metamizole: retrospective analysis of WHO and Swiss spontaneous safety reports","volume":"71","author":"Blaser LS","year":"2015","unstructured":"Blaser LS, Tramonti A, Egger P, Haschke M, Kr\u00e4henb\u00fchl S, R\u00e4tz Bravo AE. Hematological safety of metamizole: retrospective analysis of WHO and Swiss spontaneous safety reports. Eur J Clin Pharmacol. 2015, 71:209-17. 10.1007\/s00228-014-1781-z","journal-title":"Eur J Clin Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011421.pub2","article-title":"Single dose dipyrone (metamizole) for acute postoperative pain in adults","volume":"4","author":"Hearn L","year":"2016","unstructured":"Hearn L, Derry S, Moore RA. Single dose dipyrone (metamizole) for acute postoperative pain in adults. Cochrane Database Syst Rev. 2016, 4:CD011421. 10.1002\/14651858.CD011421.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12422","article-title":"Safety of metamizole: a systematic review of the literature","volume":"41","author":"Andrade S","year":"2016","unstructured":"Andrade S, Bartels DB, Lange R, Sandford L, Gurwitz J. Safety of metamizole: a systematic review of the literature. J Clin Pharm Ther. 2016, 41:459-77. 10.1111\/jcpt.12422","journal-title":"J Clin Pharm Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-015-1895-y","article-title":"Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012","volume":"71","author":"Stammschulte T","year":"2015","unstructured":"Stammschulte T, Ludwig WD, M\u00fchlbauer B, Bronder E, Gundert-Remy U. Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012. Eur J Clin Pharmacol. 2015, 71:1129-38. 10.1007\/s00228-015-1895-y","journal-title":"Eur J Clin Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13310","article-title":"Agranulocytosis attributed to metamizole: an analysis of spontaneous reports in EudraVigilance 1985-2017","volume":"126","author":"Hoffmann F","year":"2020","unstructured":"Hoffmann F, Bantel C, Jobski K. Agranulocytosis attributed to metamizole: an analysis of spontaneous reports in EudraVigilance 1985-2017. Basic Clin Pharmacol Toxicol. 2020, 126:116-25. 10.1111\/bcpt.13310","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-004-0836-y","article-title":"Agranulocytosis associated with dipyrone (metamizol)","volume":"60","author":"Ib\u00e1\u00f1ez L","year":"2005","unstructured":"Ib\u00e1\u00f1ez L, Vidal X, Ballar\u00edn E, Laporte JR. Agranulocytosis associated with dipyrone (metamizol). Eur J Clin Pharmacol. 2005, 60:821-9. 10.1007\/s00228-004-0836-y","journal-title":"Eur J Clin Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-019-01774-4","article-title":"Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data","volume":"393","author":"Klose S","year":"2020","unstructured":"Klose S, Pflock R, K\u00f6nig IR, Linder R, Schwaninger M. Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data. Naunyn Schmiedebergs Arch Pharmacol. 2020, 393:681-90. 10.1007\/s00210-019-01774-4","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref12","unstructured":"Metamizole-containing medicinal products - CHMP Assessment Report. (2018). Accessed. December 10, 2025: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/metamizole-article-31-referral-chmp-assessment-report_en.pdf."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/441515-learning-from-the-uncommon-in-common-practice-a-case-report-on-metamizole-induced-agranulocytosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T13:42:02Z","timestamp":1766065322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/441515-learning-from-the-uncommon-in-common-practice-a-case-report-on-metamizole-induced-agranulocytosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.99539","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,18]]}}}